ScoreWhy is Nutex Health, Inc. ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.16 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 221.06%
3
With a growth in Net Sales of 76.51%, the company declared Outstanding results in Mar 25
- The company has declared positive results for the last 4 consecutive quarters
- NET SALES(Q) At USD 211.79 MM has Grown at 76.51%
- OPERATING CASH FLOW(Y) Highest at USD 71.06 MM
- NET PROFIT(HY) Higher at USD 76.81 MM
4
With ROE of 76.34%, it has a attractive valuation with a 3.44 Price to Book Value
- Over the past year, while the stock has generated a return of 248.36%, its profits have risen by 1704.1%
5
High Institutional Holdings at 24.99%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.88% over the previous quarter.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Nutex Health, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nutex Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Nutex Health, Inc.
307.14%
16.17
115.06%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
221.06%
EBIT Growth (5y)
114.52%
EBIT to Interest (avg)
3.68
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
2.04
Tax Ratio
18.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.99%
ROCE (avg)
65.61%
ROE (avg)
55.87%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
5
Industry P/E
Price to Book Value
3.44
EV to EBIT
3.08
EV to EBITDA
2.82
EV to Capital Employed
3.97
EV to Sales
1.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
128.63%
ROE (Latest)
76.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend36What is working for the Company
NET SALES(Q)
At USD 211.79 MM has Grown at 76.51%
OPERATING CASH FLOW(Y)
Highest at USD 71.06 MM
NET PROFIT(HY)
Higher at USD 76.81 MM
ROCE(HY)
Highest at 51.65%
PRE-TAX PROFIT(Q)
At USD 62.76 MM has Grown at 111.96%
RAW MATERIAL COST(Y)
Fallen by -290.33% (YoY
CASH AND EQV(HY)
Highest at USD 131.25 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 128.71 %
-8What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.42 times
INTEREST(Q)
Highest at USD 6.12 MM
Here's what is working for Nutex Health, Inc.
Net Profit
At USD 76.81 MM has Grown at 1,861.27%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
At USD 211.79 MM has Grown at 76.51%
over average net sales of the previous four periods of USD 119.99 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 62.76 MM has Grown at 111.96%
over average net sales of the previous four periods of USD 29.61 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
Higher at USD 76.81 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 71.06 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 131.25 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 128.71 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -290.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Nutex Health, Inc.
Interest
At USD 6.12 MM has Grown at 21.14%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 6.12 MM
in the last five periods and Increased by 21.14% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debtors Turnover Ratio
Lowest at 3.42 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
